Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing Escherichia coli in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)

INTRODUCTION: The management of mid and low rectal cancer is based on neoadjuvant chemoradiotherapy (CRT) followed by standardised surgery. There is no biomarker in rectal cancer to aid clinicians in foreseeing treatment response. The determination of factors associated with treatment response might...

Descripción completa

Detalles Bibliográficos
Autores principales: Taoum, Christophe, Carrier, Guillaume, Jarlier, Marta, Roche, Gwenaelle, Gagniere, Johan, Fiess, Catherine, De forges, Helene, Chevarin, Caroline, Colombo, Pierre-Emmanuel, Barnich, Nicolas, Rouanet, Philippe, Bonnet, Mathilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723882/
https://www.ncbi.nlm.nih.gov/pubmed/36460331
http://dx.doi.org/10.1136/bmjopen-2022-061527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723882/
https://www.ncbi.nlm.nih.gov/pubmed/36460331
http://dx.doi.org/10.1136/bmjopen-2022-061527

Ejemplares similares